Eam Global Investors LLC Viking Therapeutics, Inc. Transaction History

Eam Global Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.72 - $9.4 $574,540 - $1.99 Million	211,228 New	211,228 $1.99 Million
Q1 2019 May 10, 2019	SELL	$7.58 - $9.94 $877,619 - $1.15 Million	-115,781 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$3.88 - $12.74 $375,444 - $1.23 Million	-96,764 Reduced 45.53%	115,781 $1.1 Million
Q1 2018 Jun 04, 2018	SELL	$4.11 - $6.93 $139,637 - $235,446	-33,975 Reduced 13.78%	212,545 $929,000
Q4 2017 Jun 04, 2018	BUY	$1.74 - $4.34 $428,944 - $1.07 Million	246,520	246,520 $1 Million

473

66.2M

5.72M

3.39M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.03B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.